PMID- 30079763 OWN - NLM STAT- MEDLINE DCOM- 20190911 LR - 20200309 IS - 1497-0015 (Electronic) IS - 0706-7437 (Print) IS - 0706-7437 (Linking) VI - 63 IP - 11 DP - 2018 Nov TI - Effectiveness of Community Treatment Order in Patients with a First Episode of Psychosis: A Mirror-Image Study. PG - 766-773 LID - 10.1177/0706743718777389 [doi] AB - OBJECTIVE: Poor adherence to antipsychotic medications is strongly associated with psychotic relapses and hospitalizations. This may hinder patients' ability to function, particularly in a first episode of psychosis (FEP). Poor adherence to treatment may be due to poor insight that can alter the capacity to consent to care, including pharmacotherapy. When patients are judged legally lacking the capacity to consent to care, treatment can be mandated through community treatment orders (CTOs). This naturalistic study examines the effects of CTOs in FEP patients. METHOD: This study examines 38 FEP patients legally deemed unable to consent to care during their follow-up. Using a naturalistic mirror-image approach, we compare clinical (Scale for the Assessment of Positive Symptoms [SAPS], Scale for the Assessment of Negative Symptoms [SANS]), functional (Global Assessment of Functioning Scale [GAF], Social and Occupational Functioning Assessment Scale [SOFAS]), and service use (number of emergency room visits, length of hospitalizations) indicators before and after CTO. RESULTS: After the CTO, 37 of 38 patients complied with treatment. Statistically significant improvements in clinical (triangle upSAPS = -6.3; 95% CI, 4.5 to 8.1 and triangle upSANS = -2.2; 95% CI, 0.9 to 3.4, P < 0.01) and functional (triangle upGAF = +15.0; 95% CI, 8.4 to 21.6, triangle upSOFAS = +18.6; 95% CI, 12.8 to 24.4, P < 0.01) outcomes were observed. Significant reduction in emergency room visits ( P = 0.016) and days of hospitalization per month in acute care units ( P < 0.05) were identified with no difference in hospital days per month in short-stay units. Moreover, encounters with case managers ( P = 0.008) and attendance of cognitive therapy sessions ( P = 0.031) were significantly higher. However, patients' weight significantly increased after CTO (triangle upweight = +8.0 kg, P < 0.01). CONCLUSIONS: In FEP patients, CTOs improve compliance to treatment, which contributes to reducing positive and negative symptoms, shortening hospital stays, and improving functioning. FAU - Levy, Emmanuelle AU - Levy E AD - 1 Department of Psychiatry, McGill University, Montreal, Quebec. AD - 2 Douglas Mental Health University Institute, Verdun, Quebec. FAU - Mustafa, Sally AU - Mustafa S AD - 2 Douglas Mental Health University Institute, Verdun, Quebec. FAU - Naveed, Kanza AU - Naveed K AD - 2 Douglas Mental Health University Institute, Verdun, Quebec. FAU - Joober, Ridha AU - Joober R AD - 1 Department of Psychiatry, McGill University, Montreal, Quebec. AD - 2 Douglas Mental Health University Institute, Verdun, Quebec. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20180805 PL - United States TA - Can J Psychiatry JT - Canadian journal of psychiatry. Revue canadienne de psychiatrie JID - 7904187 SB - IM MH - Adolescent MH - Adult MH - Cognitive Behavioral Therapy/*statistics & numerical data MH - Early Medical Intervention/statistics & numerical data MH - Female MH - Hospitalization/*statistics & numerical data MH - Humans MH - Involuntary Treatment/*statistics & numerical data MH - Male MH - Mandatory Programs/*statistics & numerical data MH - Mental Health Services/*statistics & numerical data MH - Outcome and Process Assessment, Health Care/*statistics & numerical data MH - Patient Acceptance of Health Care/statistics & numerical data MH - Patient Compliance/*statistics & numerical data MH - Psychotic Disorders/*physiopathology/*therapy MH - Quebec MH - Young Adult PMC - PMC6299184 OTO - NOTNLM OT - capacity to consent OT - community treatment order OT - first-episode psychosis OT - hospitalization OT - involuntary treatment COIS- Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Levy reports to have received a grant from Janssen for the conduct of this study and to be a speaker for Janssen, Lundbeck, and Otsuka outside the submitted work. Dr. Joober reports to be a speaker and/or consulting committee member for Pfizer, Janssen, BMS, Sunovian, Myelin, Otsuka, Lundbeck, shire, and Perdue; to have received grants from Janssen, BMS, Otsuka, Lundbeck, Astra Zeneca, and HLS; and to have royalties from Henry Stewart talks, all outside the submitted work except for the abovementioned grant. EDAT- 2018/08/07 06:00 MHDA- 2019/09/12 06:00 PMCR- 2019/05/01 CRDT- 2018/08/07 06:00 PHST- 2018/08/07 06:00 [pubmed] PHST- 2019/09/12 06:00 [medline] PHST- 2018/08/07 06:00 [entrez] PHST- 2019/05/01 00:00 [pmc-release] AID - 10.1177_0706743718777389 [pii] AID - 10.1177/0706743718777389 [doi] PST - ppublish SO - Can J Psychiatry. 2018 Nov;63(11):766-773. doi: 10.1177/0706743718777389. Epub 2018 Aug 5.